Tagged Articles

Bayer 354 articles

Lawyers will continue to fight for Xarelto victims

xarelto

Jurors in the third bellwether trial involving bleeding risks with the blood thinner Xarelto took just three hours to return a verdict in favor of drug makers Johnson & Johnson, Janssen Pharmaceuticals and Bayer. But attorneys representing the nearly 18,000 people who have filed Xarelto lawsuits say they will continue to fight for justice for those injured or killed after using the drug. “The makers of Xarelto need to be candid about the risks posed by this blood thinner,” said Andy Birchfield, one of the lead plaintiffs’ attorneys, a principal at Beasley, Allen, Crow, Methvin, Portis & Miles in Montgomery, ... Read More

Jury hears third case of Xarelto side effects

xarelto

A jury of five men and four women were selected in the U.S. District Court for the Southern District of Mississippi to hear the case of Dora Mingo, a 69-year-old woman from Summit, Mississippi, suing Johnson & Johnson’s Janssen Pharmaceuticals and Bayer over claims that their blood thinner Xarelto caused her internal bleeding. It is the third bellwether trial in a multidistrict litigation (MDL) of more than 16,000 cases making similar claims about Xarelto. Jurors in the two previous trials cleared the drug makers of liability relating to claims that the blood thinner caused users to suffer internal bleeding which ... Read More

Xarelto makers want to strike doctor’s testimony

xarelto

The makers of the blood thinner Xarelto asked the Louisiana federal judge overseeing the third bellwether trial currently underway to strike testimony from a physician about a proposed change to the drug’s safety label that was redlined by the Food and Drug Administration (FDA), according to Law360. The case involves that of Dora Mingo, who blames the blood thinner for causing her gastrointestinal bleed. She was taking the medication to treat deep vein thrombosis she developed after undergoing hip replacement surgery. She claims that Johnson & Johnson’s Janssen Pharmaceuticals and Bayer, makers of Xarelto, should have informed doctors on its safety ... Read More

Xarelto injuries ‘disheartening’

xarelto

Injuries caused by the blood thinner Xarelto are “disheartening, but unfortunately not all that surprising,” said Andy Birchfield of Beasley Allen Law Firm and co-lead council of the plaintiffs’ steering committee for the Xarelto multidistrict litigation (MDL). According to a recent study by the Institute for Safe Medication Practice (ISMP), the Food and Drug Administration (FDA) received 15,043 reports of serious injuries or death related to Xarelto last year – a 41 percent increase over the previous year. In general, oral anticoagulants like Xarelto resulted in more emergency room visits in 2016 than any other class of drugs with nearly 22,000 ... Read More

Third Xarelto lawsuit set for trial

xarelto

The third bellwether in a massive multidistrict litigation (MDL) alleging bleeding risks with the blood thinner Xarelto will move forward despite the drug companies’ attempts to squash the case before it went to trial, a Louisiana federal judge ruled. Johnson & Johnson’s Janssen Pharmaceuticals and Bayer had requested a partial summary judgment in the case of Dora Mingo, whose case is set to go to trial on Aug. 7, on the grounds that they didn’t have the authority to change the safety label of Xarelto to reflect the extent of the bleeding risks. Thus, they argued, the state claims brought by ... Read More

Bleeding most reported drug-related adverse event

xarelto

There are unacceptably high risks associated with oral blood thinners, most of which involve life threatening bleeding events, according to the Food and Drug Administration (FDA) Adverse Events database and a new systematic study by the Centers for Disease Control and Prevention (CDC). The issue was identified by the Institute for Safe Medication Practices (ISMP) in its fourth quarter QuarterWatch report. ISMP’s annual report focused on drugs and specific adverse reactions that affect large patient populations and involve substantial numbers of serious injuries. There were nearly 22,000 serious adverse events reports linked to use of anticoagulants, and in particular Xarelto, ... Read More

Xarelto mass tort grows in first half of 2017

xarelto

Lawsuits alleging bleeding risks with the blood thinner Xarelto pending in the Philadelphia Court of Common Pleas increased by 210 cases – or 17 percent – from Jan. 1 to June 14, 2017, according to Law.com. The number of cases jumped from 1,214 to 1,424. The Xarelto mass tort is one of nine pending in the Philadelphia. There are also about 1,600 Xarelto lawsuits that have been consolidated in a multidistrict litigation (MDL) in the Eastern District of Louisiana under Judge Eldon E. Fallon. Two Xarelto cases in the MDL have been heard, with the third scheduled for August. A total ... Read More

Pradaxa antidote effective in new study

blood cells

Praxbind, a drug that reverses the blood thinning properties of the anticoagulant Pradaxa in the event of a bleeding emergency, was found to be safe and effective enough for urgent use even if patients later prove not to have little or no Pradaxa in their bloodstream, researchers concluded in a study published in the New England Journal of Medicine. Dr. Charles Pollack, Jr., with Thomas Jefferson University in Philadelphia, and colleagues, conducted a full cohort analysis of the reversal effects of Praxbind, which contains the active ingredient idarucizumab. Praxbind and was approved by the Food and Drug Administration (FDA) in ... Read More

Xarelto makers hit with two new lawsuits

xarelto

Two new lawsuits have been filed in New York state court against Johnson & Johnson’s Janssen Pharmaceuticals and Bayer alleging the drug companies downplayed risks with their blood thinner Xarelto, Law360 reports. The lawsuits were filed by Thomas Walsh and Joseph Roman, and on behalf of their wives. The men claim they suffered “life-threatening bleeding” and “other severe and personal injuries” after taking the medication, and that Bayer and Janssen knew of its “serious and dangerous side effects” but failed to adequately warn doctors or their patients. Furthermore, their lawsuits state, the drug companies did not perform adequate human tests ... Read More

Eliquis bleeding risks case filed in NY

blood cells

Bristol-Myers Squibb Co. and Pfizer Inc. skimped on pre-approval testing and withheld information about bleeding risks with their blood thinner Eliquis, loved ones of a man who died after taking the drug told a New York state court, Law360 reports. Raymond Warme, father of Dawn Dunn and partner of Orla Troy, was prescribed Eliquis in April 2014 to prevent strokes associated with his heart rhythm irregularity called atrial fibrillation. About two months later, Warme started bleeding internally and soon after died from his injuries. Dunn and Troy claim that the drug makers conducted clinical trials in China using “incompetent and ... Read More